SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT - KTUL.com - Tulsa, Oklahoma - News, Weather & Sports

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Levi & Korsinsky, LLP

NEW YORK, Aug. 27, 2014 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of investors who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities between January 6, 2014 and July 28, 2014.

Protecting the Rights of Shareholders

For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt.

The complaint alleges that during the Class Period the Company violated federal securities laws by issuing false and misleading statements regarding its business and prospect. As a result of these statements, Galectin stock traded at artificially inflated prices.

On July 28, 2014, an article featured on TheStreet.com noted that Galectin hired a stock promotions firm known as Emerging Growth Corp. to tout its stock. The article further notes that Emerging Growth "describes itself as an investor relations and marketing company, but that it's just a shiny façade on what is really an ugly penny-stock promotions scheme." The following day Galectin reported disappointing results regarding its phase 1 experimental drug trial for GR-MD-02.

If you suffered a loss in Galectin you have until September 29, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/galectin-therapeutics-galt.   

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C.  The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

P.O. Box 8 Tulsa, OK 74101-0008

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and KTUL. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.